
What smart money is saying about Inogen Inc.
1 fund in our archive has pitched Inogen Inc. — most recently Jacob Funds in September 2025.
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Get an email when a fund writes about it
Fund coverage · 1 thesis
- Jacob FundsSeptember 2025
Inogen is stabilizing its business with strong management and a dominant market share in portable oxygen concentrators, poised for growth amid an aging population.
Read the full thesis
Read every full thesis on Inogen Inc.
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→